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Abstract
Background: In the United Kingdom (UK) in September 2008, school nurses began delivering the HPV
immunisation programme for girls aged 12 and 13 years old. This study offers insights from school nurses’
perspectives and experiences of delivering this new vaccination programme.
Methods: Thirty in-depth telephone interviews were conducted with school nurses working across the UK
between September 2008 and May 2009. This time period covers the first year of the HPV vaccination programme
in schools. School nurses were recruited via GP practices, the internet and posters targeted at school nurse
practitioners.
Results: All the school nurses spoke of readying themselves for a deluge of phone calls from concerned parents,
but found that in fact few parents telephoned to ask for more information or express their concerns about the
HPV vaccine. Several school nurses mentioned a lack of planning by policy makers and stated that at its
introduction they felt ill prepared. The impact on school nurses’ workload was spoken about at length by all the
school nurses. They believed that the programme had vastly increased their workload leading them to cut back on
their core activities and the time they could dedicate to offering support to vulnerable pupils.
Conclusion: Overall the first year of the implementation of the HPV vaccination programme in the UK has
exceeded school nurses’ expectations and some of its success may be attributed to the school nurses’
commitment to the programme. It is also the case that other factors, including positive newsprint media reporting
that accompanied the introduction of the HPV vaccination programme may have played a role. Nevertheless,
school nurses also believed that the programme had vastly increased their workload leading them to cut back on
their core activities and as such they could no longer dedicate time to offer support to vulnerable pupils. This
unintentional aspect of the programme may be worthy of further exploration.
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Background
Human papillomavirus (HPV) is a common sexually
transmitted infection. It is estimated that 20% of sexually
active girls will contract the virus by the age of 18 years
[1] and up to 80% of women will have had an infection
by the time they reach 50 years of age [2]. Despite its fre-
quency, only a small proportion of women who develop
persistent infection from high risk genotypes go on to
develop cervical cancer; 70% of infections clear within
one year and around 90% within two years [3].
The new HPV vaccine was introduced into the United
Kingdom (UK) in September 2008, to protect girls
against two high risk strains of HPV that cause around
70% of cases of cervical cancer [4]. For the HPV vaccina-
tion programme to be most effective it is recommended
that young people are given the vaccine before they
become sexually active [5]. In view of this, the UK Joint
Committee for Vaccination and Immunisation recom-
mended targeting the HPV vaccination programme at
girls aged 12 and 13, with a catch-up campaign for girls
up to 18 years of age being carried out over a three-year
period. To maximise its uptake and effectiveness the
three-dose schedule is delivered in schools by school
nurses over six months as part of the publicly funded
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National Health Service. Research has yet to determine
whether booster vaccines will be needed at a later date
for women who received the vaccine as adolescents, and
so continued cervical screening is essential for all women
[6]. School nurses play a key role in the successful imple-
mentation of the HPV vaccination programme. A key
challenge of implementing it will be its acceptability to
parents, their daughters and the health care providers
(school nurses) involved in delivering the programme in
schools. One potential barrier to uptake is a lack of
awareness about the role HPV infection plays in cervical
cancer [7]. In a recent study of a representative sample of
British women (n = 1620), only 2.5% cited HPV as a
cause of cervical cancer and awareness of HPV was low-
est in those with least formal education [8]. Similarly, in
a questionnaire survey of 1032 women attending a Well
Woman clinic in London (UK) about 30% recognised
HPV only in name. On further questioning, less than half
knew of the link with cervical cancer and there was con-
fusion about whether condoms or oral contraceptives
could prevent HPV infection [9]. In a more recent study
of a representative sample of British women (n = 1620), a
quarter of respondents were aware of HPV, and aware-
ness was lower among those with less formal education
[8]. Research examining HPV awareness and understand-
ings among the target age of 12 to 18 year old girls has
received far less attention despite the acknowledgement
that: “Engaging adolescent girls is critical to avoid mis-
conceptions about the protection afforded by HPV vacci-
nation and the future need for cervical screening” [10].
Similarly, the knowledge and attitudes of service provi-
ders are known to be important factors in influencing
vaccine acceptability, but as yet little is known about
school nurses’ views on the HPV programme. One quali-
tative study conducted ahead of the introduction of the
programme sought the views of school nurses on vacci-
nating girls who did not have parental consent. Using in-
depth interviews Stretch and colleagues [11] found that
school nurses (n = 15) were reluctant to vaccinate if par-
ents had refused permission, felt confused about the legal
guidelines governing consent and so would defer vaccina-
tion, rather than vaccinate without parental consent.
They suggested that to facilitate the legal right of girls
below the age of 16 years to self-consent, school nurses
would need more training and support on this issue.
In the first year of the programme, HPV vaccine uptake
among the 12 to 13 cohort in England has been above
80% and in Scotland almost 90% for the three doses
[12,13]. These uptakes rates are higher than those
reported from a pilot study in Manchester in which rates
of 70.6% (first dose) and 68.5% (second dose) were
achieved [14]. These figures also exceed the level at
which the programme is deemed to be financially cost
effective [5]. Acceptability rates have also been high (over
80%) in the ‘catch up’ cohort aged 17 to 18 years for all
three doses in Scotland. However, in England only one in
three 17-18 year olds accepted all three doses [12,13].
Any sub-optimal uptake in the older cohort of girls could
be construed as disappointing given that in the UK there
are around 2800 new cases of cervical cancer and
approximately 950 deaths each year [15] and given the
level of media publicity that coincided with the launch of
the HPV programme following reality television star Jade
Goody’s diagnosis and death from cervical cancer [16].
Such publicity was expected to raise public awareness
about the ‘severity’ of cervical cancer, a factor which is
known to be important when deciding about vaccination
[17]. This study offers some of the first insights from
school nurses’ perspectives and experiences in delivering
the HPV vaccination programme in its first year. In parti-
cular, to investigate school nurses’assessment of the HPV
vaccine, their experiences of delivering the school based
programme, and their views on parental decision-making
about HPV vaccination which may help guide its future
implementation.
Methods
Sampling and recruitment
Thirty in-depth telephone interviews were conducted with
school nurses between September 2008 and May 2009 to
cover the first year of the HPV vaccination programme in
schools in the UK. School nurses were recruited across the
UK via adverts on the Royal College of Nurses website
(n = 22), posters advertising the study at the 2007 Com-
munity Practitioners’ and Health Visitors’ Annual Confer-
ence (n = 5) and from snowballing through GP practices
(n = 3). Purposive sampling was used to obtain a diverse
sample of school nurses in terms of the number of years’
experience as a school nurse, age, geographical location
and parental status. School nurses were also targeted to
include those working in schools in deprived, affluent,
rural and urban locations. To identify our purposive sam-
ple we administered a short questionnaire over the tele-
phone prior to interview (see additional file 1, appendix 1).
Data collection and analysis
The interview schedule was developed from the literature
and by first conducting several short telephone interviews
with immunisation and child health specialists, public
health specialists and health policy makers (n = 10) to
gather information on the key issues. The interviews were
semi-structured using open-ended questions enabling a
qualitative approach to gain deeper insights to explore
school nurses’ views and experiences of these key areas
(see additional file 1, appendix 1). Inductive modes of
thinking are particularly useful when the aim is to
describe, explore, understand, or explain a particular phe-
nomenon. It may consider the ‘what’, ‘why’ and ‘how’ of
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the phenomenon, but not in terms of ‘how many’ or ‘how
frequently’ [18] (p. 7). The schedule included broad ques-
tions examining their assessment of the HPV vaccine,
their experiences of delivering the school based pro-
gramme, and their views on parental decision-making
about HPV vaccination. In addition, the schedule con-
tained more specific probing questions, and the interviews
allowed flexibility for nurses to raise issues themselves.
To obtain a diverse sample, prior to conducting the
interview all the potential respondents were asked ques-
tions about the number of years’ experience as a school
nurse, age, geographical location, parental status, caseload.
At this stage they were posted a consent form to return in
a pre-paid envelope and a time and date for the interview
were arranged. All the interviews were conducted by SH by
telephone from their own home, and lasted approximately
45 minutes. In keeping with MRC policy all the interview
tape recordings were kept in a locked drawer and all
names removed from transcripts to ensure anonymity. All
the interviews were recorded and transcribed verbatim.
Each transcript was checked against the audio-recording,
then re-read and thematically coded. Following the princi-
ples of the constant comparative method and rigorous ana-
lysis, [19] which enable systematic comparisons to be made
across the large amounts of data, each transcript was
repeatedly re-examined and cross-compared to identify
common themes. Once all the relevant themes were coded,
a coding frame was developed and SH, KH, HB and MP
reviewed the data to identify links between themes, domi-
nant discourses and to identify deviant or contradictory
cases [20]. To report the data we have used concise quotes;
we indicate where these were ‘typical’ of a broader range of
views or were ‘atypical’, deviating from commonly held
viewpoints. For transparency we have identified the ques-
tion the facilitator asked and have indicated where topics
emerged spontaneously from the nurse participants them-
selves. Ethical approval for the study was obtained from
the research ethics committee of the University of Glas-
gow’s Law, Business and Social Sciences Faculty.
Results
Thirty school nurses took part in telephone interviews.
Seventeen were parents themselves, 4 worked with a pre-
dominantly deprived caseload, 3 worked with a predomi-
nantly affluent caseload and 23 described their caseload as
mixed. They were an experienced group of school nurses
with a length of service ranging from 5 years up to
36 years.
Confidence in the HPV vaccine and programme
School nurses were asked about their feelings towards the
HPV vaccine and programme. Most of the school nurses
were supportive of the programme and considered them-
selves well placed to implement it. They frequently
mentioned their belief that they were implementing a pro-
gramme that would make a real difference towards future
cervical cancer prevention. For instance, one school nurse
said that:
“we (school nurses) have stressed to the girls that
they’re a very fortunate group of young ladies, you
know, the first people that will actually have had a vac-
cine that will help prevent a cancer and for us to be
part of that, it’s really actually quite something” (SN 18).
Generally school nurses felt confident in the safety of the
HPV vaccine and either mentioned that they planned to
consent for their own daughters to have it, or stated
hypothetically that if they had a daughter they would have
no hesitation in consenting. For example, one school
nurse said:
“if I had a daughter I would have no problem in giv-
ing her it. I feel quite happy and secure that the vac-
cine is as safe as it can be and has been tested
rigorously” (SN15).
However, when asked whether they would be happy to
vaccinate a girl under 16 years of age whose parents had
refused to consent for the vaccine, almost all of the
school nurses did not think that they would feel comfor-
table going against the wishes of the parents. No school
nurses had actually had to deal with this situation.
Commonly, school nurses mentioned that they felt they
were making a positive contribution to girls’ health beyond
the school years. For example, one school nurse stated:
“I’m so pro this vaccine it’s not true because, obviously, it’s
the first one we’ve got against cancer and we can help pro-
tect these girls long-term” (SN26). Similarly, another
school nurse stated: “I don’t have any qualms about giving
the girls the vaccine because I think it’s a very positive
thing for their future health” (SN28). Whilst most school
nurses were extremely positive about HPV vaccination,
there were two nurses who were more cautious in talking
about the programme and its safety. One questioned the
value of the vaccine: “...really how much good the vaccine
will do in these kids? In my mind it still needs established”
(SN14). The other said:
“I don’t know about its safety. I’m just giving it
because I’ve been told to give it. We’ve been told it’s
perfectly safe so it probably is, it probably is a good
thing, but I don’t know” (SN30).
Feelings about HPV vaccination policy
All the participants were asked a broad question on vac-
cination policy: ‘How do you feel about the decisions
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the government have made in relation to HPV vaccina-
tion policy in the UK?’. Four main issues arose: the age
range of the girls; the decision to target girls and
exclude boys from the programme; the decision to opt
for the Cervarix© vaccine over its competitor, Gardasil©;
and the perceived policy decision to market the vaccine
to prevent cervical cancer rather than to protect against
the sexual transmission of HPV infection. Most school
nurses mentioned that in their experiences they thought
a minority of girls did become sexually active at a very
young age and therefore targeting girls as young as 12
years of age seemed “appropriate” and “right” (SN22).
School nurses mentioned that the younger girls were
also easier to immunise as parents were more involved
in the decision (SN8) and the girls presented with less
needle phobia (SN30). However, three school nurses sta-
ted that they believed the upper age limit should be
extended to take account of the fact that many girls
may not have the virus if they have been in longer-term
relationships (SN9, SN7, SN30). When asked what they
would like the upper age limit to be extended to,
answers varied from 21 years to 24 years.
School nurses were divided about whether boys should
have been included in the programme. They were all
aware of the high cost of the vaccine and this led some to
suggest a need to ration this vaccine to girls who have the
most to benefit (SN17). It was also suggested that had
boys been included in the programme, the uptake rate of
the vaccine would be lower because parents would not
regard it as relevant for their sons (SN12). One school
nurse stated boys would benefit through herd immunity:
“obviously if girls are protected against HPV, it’ll not be
passed on to someone else’s son” (SN1). In contrast, there
was concern among some school nurses that boys were
“being excluded from taking responsibility for health”
(SN23), that it “reinforces and promotes the idea that it’s a
girly thing to look after sexual health” (SN29) and “...it
removes any joint responsibility between the sexes for
health” (SN16). Some school nurses felt they were “...send-
ing out mixed messages about sexual health responsibility”
(SN8).
The decision to opt for the Cervarix© vaccine over Gar-
dasil© was widely viewed among school nurse respon-
dents as a cost-based rather than evidence-based
decision. Most school nurses stated that before the gov-
ernment announcement to use Cervarix© they had
expected the vaccine of choice to be Gardasil© on the
grounds that “it offers some protection against cervical
warts as well as cervical cancer” (SN5). The lack of trans-
parency was spoken about by some school nurses as:
“frustrating because people become suspicious and irate
when things aren’t clear...” (SN17). Despite these con-
cerns most school nurses also mentioned that they
thought the decision to opt for Cervarix© probably made
their job of trying to attain a high uptake easier. The
primary reason given for this view was because the mar-
keting of the Cervarix© vaccine had been focused on tar-
geting girls and their parents and so was: “...deliberately
very pink and joyful, you know and about doing the right
thing for securing their daughter’s future health” (SN14)
and “...obviously being sold as a girl’s cervical cancer pre-
vention jab, not as an unattractive sexually transmitted
diseases jab” (SN28). However, this marketing strategy
led some school nurses to raise concerns about whether
the prime focus on cervical cancer rather than sexually
transmitted infections may have missed opportunities to
educate parents and teenagers of the need to use barrier
methods (SN24) and for girls to attend for future cervical
screening (SN21), and some worried that it would make
it difficult in the future to extend the programme to
include boys (SN17, SN7, SN2).
Experiences of implementing the programme
Out of the thirty school nurses, twenty four described
the introduction of the programme as ‘rushed,’ ‘too hur-
ried’ or ‘too fast’ and many of them stated that in the
weeks leading up to its introduction they felt ill pre-
pared. One school nurse described feeling that she and
her colleagues were: “...kind of groping in the dark”
(SN17). Another recalled: “Oh it’s been way too rushed
and it’s caused a lot of unnecessary panic and stress...
really we’ve been thrown in at the deep end” (SN 28).
There was general agreement across the interviews that
it could have been planned better and had had a huge
impact on their workload. For instance, it was stated:
“... there wasn’t enough preparation early enough
around doing these vaccines...we didn’t have training
until a fortnight before it happened, it was way into
September (i.e. the month that the programme was
introduced into schools in Scotland) and we only
got one training day. I mean we knew this pro-
gramme was going to happen, well, from last year”
(SN18).
Similarly another school nurse stated
“it was rushed, too hurried. It was really difficult, the
decision was made for Cervarix© just before the sum-
mer holidays, we were supposed to get the leaflets
and stuff over the summer holidays, which anyway
was daft, cos we don’t work in summer holidays, so
we came back to everything to do. It had a huge
impact on my workload” (SN11).
Several school nurses mentioned a lack of planning by
policy makers: “I don’t think the planners realised that
three weeks after they told us which vaccine they were
using, the school nurses were going off for their six week
break” (SN26). The impact on school nurses’ workload
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was spoken about at length by all the school nurses. They
all spoke about prioritising their child protection work
and having to cut back on core work such as: planned
health education sessions, running drop-in services and
delays in health assessments. Of most concern to school
nurses was the fact that they were no longer able to dedi-
cate time to offering one to one support to vulnerable
pupils and that this might adversely affect their relation-
ship with the pupils to whom they offer regular support.
One school nurse described the implementation of the
programme as:
“...a logistical nightmare... kids are used to knocking
on our door and me being here, if you’re not here,
they feel you’re not here for them, then they want
you less, that’s the relationship that I have. It will
take a knock” (SN25).
Another school nurse said
“You feel by not being here you are just another
adult not being here for them when they need you,
and if the school gets a really bad service they end
up looking elsewhere for the support. Once you’re
taken out of the school then you have to re-establish
your relationships again” (SN1).
To prevent the breakdown of established services
some school nurses spoke of working additional hours
or having requested additional staff to help with the vac-
cination programme. Where extra staff were provided,
these school nurses tended to talk more positively about
the programme’s implementation. One school nurse
suggested that: “...if you’re adequately staffed, like we
are, it can be absolutely superb no doubt about that”
(SN15). In contrast, where school nurses had to cut
back on services they had established, either because no
additional support was offered or because extra
resources were late in coming, school nurses were more
likely to air frustrations about its implementation. One
frustrated school nurse said:
“In theory, we did have extra resources to manage
but it never materialised on the first round and we
were doing everything so had to cut out our usual
work” (SN18).
Another stated: “We are struggling as a team. It has
exhausted everybody. The sickness levels have shot up,
and it’s frustrating, all our other work ceased completely
during the time we were vaccinating” (SN17).
It was common for school nurses to suggest that in its
first year of implementation school nurses had played a
central role in achieving a high uptake among school
girls. One school nurse summed up her views on its
implementation:
“I think the success of the programme will be
demonstrated by the commitment of the school
nurses and their willingness to put the perceived
needs of the children and families above their own...
bottom line is, as a team we’ve got together and
thought ‘well this has got to be done... let’s just get
on and do it’ “ (SN 8).
Perspectives on parental vaccine decision-making
All the school nurses spoke of readying themselves for a
deluge of phone calls from concerned parents, but
found that in fact few parents telephoned to ask for
more information or express their concerns about the
HPV vaccine: “I expected to be sitting here at my desk
absolutely inundated with calls and I was really not”
(SN24). Of the telephone calls they received, most were
from parents whose daughters were not in the target
age groups in the first wave of the programme, but who
were eligible for the catch-up programme, wanting to
know when their daughter’s school year would be called
to receive the vaccine. Other common telephone calls
were from parents (usually mothers) wanting to know
how to get the vaccine for girls older than 18 years of
age. School nurses described these early interactions
with parents as “extremely positive” (SN 9) and
described parents’ interest and willingness for HPV vac-
cination as “...absolutely astounding” (SN 27).
Based on their experience of delivering the first HPV
dose all the school nurses believed they would achieve a
high uptake. Some nurses had received a few telephone
calls from parents whose daughters had allergies or
from parents who did not wish their daughters to have
the vaccine. Of the parents who did refuse HPV vacci-
nation, school nurses stated that parents tended to write
their reasons for refusal on the back of the consent
forms. They identified three main reasons for parental
refusal: allergies to latex; a belief that their daughter was
not sexually active and therefore not at risk from a HPV
infection; and concerns about unknown long-term side-
effects of the vaccine on their daughter’s fertility or that
the vaccine could transmit the HPV infection (SN 8).
None of the school nurses recalled any parents refusing
HPV vaccination on the grounds that it might encou-
rage their daughters to adopt more risky sexual
behaviours.
From in-depth discussions with school nurses, nurses
identified four patterns of vaccine decision-making
behaviours (we have termed these: active acceptors, pas-
sive acceptors, passive rejectors and active rejectors).
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They also spoke of adopting different strategies to deal
with these types of decision-making behaviours.
Active acceptors
School nurses generally considered that most parents
were actively engaged in the process of making a decision
about HPV vaccination and most girls knew why they
were getting the vaccine. In their experience the vast
majority of parents they had spoken to appeared to be
interested in and well informed about the HPV pro-
gramme and believed that their daughter would be better
off vaccinated to reduce the risk from cervical cancer.
For example, one school nurse stated:
“most parents understand about cervical cancer, they
know that this vaccine is to prevent cervical cancer,
which is why their daughters are being given this
vaccination” (SN 21).
School nurses reported that few parents contacted them
asking for more information or with concerns about the
vaccine as further evidence that most parents already ‘felt’
informed and had found the decision-making process
trouble free. For instance one school nurse reported that:
“...although in our covering letter it said please con-
tact the school nurse, nobody wanted more informa-
tion, they all signed the consent and wanted the
vaccine” (SN 16).
When parents did phone with concerns (such as their
daughter having a needle phobia), the nurses believed
these parents needed reassurance rather than more infor-
mation about the pros and cons of HPV vaccination.
Passive acceptors
However, school nurses also considered that there were a
large number of parents and school girls who were not
particularly well informed but simply trusted the advice to
have HPV vaccination. When asked why they thought so
many parents and school girls readily accepted HPV vacci-
nation, school nurses responded that people know about
and fear cervical cancer even if they do not understand the
role HPV plays in its aetiology. One such response was:
“Whatever your educational attainment is, you know what
cancer is, people don’t really need to know the rest” (SN7).
Similarly, another said: “People all know someone who has
been affected. Cervical cancer is something that does
touch a lot of people’s lives” (SN18). According to school
nurses the fact the HPV vaccine was often called the
‘cervical cancer’ vaccine would be enough information for
some people.
Passive rejectors
The issue of apathy amongst parents was raised by most
of the school nurses and spoken about at length by
those who were working in schools in very deprived
areas. One school nurse stated:
“We have a lot of parental apathy, rather than a par-
ent ringing us up and saying: ‘Oh, I’m not very happy
about this injection,’ we don’t really get that side of it.
It’s more they don’t make any decision and don’t
bother signing the form. I’m having girls coming to
me and because in this community the parents have
no parental control or interest- I mean that’s a broad
statement, but I’m talking about ninety percent of my
caseload, it’s really down to the girls at the end of the
day, even if she’s only twelve or thirteen, to call the
shots” (SN7).
Another school nurse described her frustrations with
these parents: “they’re just not bothered to send it back
(consent form) and the girls would arrive saying, ‘oh
nobody’s signed it’ “. She went on to state that for these
parents: “health isn’t a priority. It’s just getting by in life
sort of thing, you know, so they don’t bother returning the
form, they lose the form and they don’t bother getting
another one” (SN 22). It was also common for school
nurses to mention that the older cohort of school girls
were more challenging to vaccinate because many would
not bother turning up for the vaccine. To obtain consent
from such parents and girls a few school nurses spoke
about phoning up parents and doing home visits to obtain
the required signed consent or cornering girls in the
school corridors to ask why they had not turned up. One
school nurse recalled a recent experience:
“They couldn’t be bothered to read the form or fill it
in, you know, motivate themselves enough to do it,
but they always wanted the child to have it (the vac-
cine) as long as somebody bothered to knock on
their door and say, ‘just sign on the dotted line’. It
was just the process of the filling the form in was
just too much effort” (SN16).
Another example also mentioned by school nurses as
evidence of parental apathy was low attendance numbers
at parent information sessions. Nine school nurses had
run HPV vaccination information sessions for parents, of
which five were described as poorly attended. School
nurses suggested a need to follow up these parents and
girls with reminder consent forms, targeted information
and flexible vaccination sessions.
Active rejectors
A fourth group of parents identified by the nurses were
those who attended organised information sessions to
express what was described as an “anti-immunisation
stance” (SN23). These parents were described as being
Hilton et al. BMC Infectious Diseases 2011, 11:226
http://www.biomedcentral.com/1471-2334/11/226
Page 6 of 9
“armed with misinformation” (SN2). They were seen as:
“...hostile and challenging to deal with” (SN13), and
potentially harmful since: “...they often sounded adamant
and could influence other parents to refuse vaccination”
(SN1). For instance, one nurse described a parent as
being “aggressively disruptive” at an evening information
session. She recalled that this parent: “had already made
her mind up that her daughter was not going to have the
vaccine and just came along simply to be controversial
and to simply cause trouble” (SN6). Similarly, another
nurse described one parent “dominating discussion” at an
information evening she had run and said that the ses-
sion descended into a question and answer exchange on
whether children were being used as “guinea pigs”
(SN26). In general school nurses considered that they
would be least able to change the views of this group of
parents and described offering them the least advice
(SN30). School nurses also identified girls in the older
cohort as rejecting the HPV vaccine. The main reason
cited was that they had a needle phobia. These girls were
characterised as lacking an understandings of HPV, the
rationale for the vaccine’s introduction, and the need to
prioritise health.
Experiences of trying to influence parents and school
girls
School nurses were asked, which parents or school girls
they found they have least influence in assisting them to
make a decision about HPV vaccination. Commonly,
nurses suggested that those parents who did phone or
attend information sessions were those in least need of
the information. Conversely those that they felt would
benefit the most tended not to phone or show up. For
this reason it was common for school nurses to suggest
that parent information session would be ineffectual in
affecting vaccine decision-making, stating:
“the same faces turn up...parents that have already
made their decisions, whereas the hard to reach par-
ents that haven’t given it any thought don’t turn up.
They look to you (school nurse) to rectify any problem
and just sort it out getting their child immunised”
(SN 2).
However when asked which parents, if any, they had
most influence over, school nurses tended to believe
they had most influence over parents with the greatest
health needs typically from more deprived backgrounds.
One school nurse suggested:
“...I think people from slightly poorer backgrounds
expect you to do more hands-on things and be able
to fix everything... people from slightly poorer back-
grounds are often more likely to actually follow the
advice you give, if you have that trust you can engage
with them and they are more likely to listen and work
with you rather than argue with you, whereas the
more affluent parents sometimes think they know
best...” (SN 29).
Indeed, it was common for school nurses to assess
that as a general rule they have more experience of
working with less affluent parents; the more affluent
parents they did come into contact with were charac-
terised as less typical of parents generally and very chal-
lenging individuals. One school nurse concluded:
“...we (school nurses) have a certain level of knowl-
edge, but we don’t have the knowledge that these
parents that have spent hours researching- you
know- they’re sort of referring to twelve sources.
They’ll have done their own literature review on
everything and they will just be challenging your
knowledge really- not taking in what you’re saying”
(SN 16).
When encouraged to identify whether there may be
tangible ways to influence the uptake of the HPV vaccine,
school nurses suggested a need to continue targeting par-
ents who take little interest in their daughter’s health
with information, consent forms and flexible HPV vacci-
nation appointments and to do likewise for those older
girls who initially refused the vaccine because of needle
phobias.
Discussion
An advantage of using home based telephone interviews
was that we found that we could recruit school nurses rea-
sonably easily and that they could speak frankly about
their views. However it is possible that the interviews were
shorter than would have been the case if they had been
face to-face interviews. Another limitation of this study is
that the school nurses who participated may not be typical
and may represent the more engaged members of their
profession; nevertheless much of their experience finds
resonance with findings from other studies. The school
nurses who took part were generally well informed and
willing to recommend HPV vaccination to parents and
adolescents. However, findings from a online question-
naire which surveyed health professionals found that there
was widespread support for the vaccination programme
[21]. Similar to findings of Lansley and Bedford (2003)
who examined immunisation co-ordinators’ views of the
Meningitis C campaign when it was introduced in 1999,
much of the credit for the high uptake of vaccines should
go to the health professionals implementing the pro-
gramme [22]. School nurses considered themselves well
placed to implement the school based programme and
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viewed the programme as a means of making a positive
contribution to girls’ health beyond the school years.
Whilst they felt positive about the programme, they also
believed that the programme had been unnecessarily
rushed and had vastly increased their workload leading
them to cut back on their core activities. Of particular
concern was that they could no longer dedicate time to
offer support to vulnerable pupils which they assessed as
having a detrimental effect on the nurses’ everyday prac-
tice and relationship-building with vulnerable pupils.
These findings suggest a shift in responsibilities for health
and raise questions over which pupils might be uninten-
tionally left behind as a consequence of the vaccination
policies and practices.
In relation to HPV policy, school nurses generally
understood the rationale for targeting girls aged 12 to 13
years and, contrary to other findings [23], viewed younger
adolescents as good candidates for these vaccines and
easier to attain consent. However, school nurses raised
concerns that by targeting the HPV programme solely at
girls, boys were being excluded from taking responsibility
for their role in spreading the virus. Such concerns draw
parallels with Polzer and Knabe’s assertions that the mar-
keting of HPV vaccines directly at women may reinforce
assumptions about the female body as the primary vector
of sexually transmitted infections (STIs) [24]. Whilst
school nurses did not suggest that the vaccine should
also be given to boys at present because of its high cost
and need to ration health services, the marketing of the
vaccine as a girls’ vaccine could have implications for the
future programme should it be rolled out to include boys
if they do not regard the vaccine as relevant for their
health. In this respect ‘gendering’ vaccines can be proble-
matic. Previous research examining parents’ views on
vaccine preventable diseases found that rubella and
mumps vaccines were perceived to be strongly gendered,
rubella being commonly seen as an issue for girls and
mumps for boys leading some parents to doubt the need
for boys to be vaccinated against rubella, and girls against
mumps [25].
As suggested by Szarewski [26] the school nurses found
the lack of transparency of the Department of Health’s
decision to opt for Cervarix© over Gardasil© frustrating.
However, similar to Kane’s suggestion [27], school nurses
also supported the decision to opt for Cervarix© and felt
it could more easily be promoted to parents as a cervical
cancer vaccine rather than a STI vaccine, enabling them
to attain higher uptake. However, some school nurses
considered there was a need to promote greater aware-
ness about HPV vaccination to avoid misconceptions
that barrier methods and cervical screening are no longer
needed. This echoes other research [10].
In relation to HPV vaccine decision-making school
nurses identified three main reasons for parental refusal:
allergies to latex, a belief that their daughter was not
sexually active and therefore not at risk from a HPV
infection, and concerns about unknown long-term side-
effects of the vaccine on their daughters’ fertility or that
the vaccine could transmit the HPV infection. School
nurses also identified needle phobia as a key reason for
refusal among the older girls. In contrast to Monk and
colleagues’ finding that some parents may not give con-
sent to vaccinate if they think their daughters will be
given information that might encourage sexual risk tak-
ing [28], school nurses in this study did not recall any
parents refusing HPV vaccination on the grounds that it
might encourage their daughters to adopt more risky
sexual behaviours.
School nurses generally considered that most parents
were actively engaged in the process of making a decision
and supported the vaccination programme, a finding
consistent with research piloting the acceptability of the
vaccine among parents in Manchester [14]. School nurses
also believed that there were also many parents who were
‘passive acceptors’ who consented for their daughter to
have the vaccine without much thought. Another group
of parents that school nurses identified and raised con-
cerns about were the large number of parents who did
not consent for their daughters to be immunised due to
what was described as ‘parental apathy’; we have termed
such parents ‘passive rejectors’. These parents were iden-
tified by school nurses as tending to come from deprived
communities for whom health may not be the highest
priority. School nurses believed that they could have
most influence in increasing HPV uptake among these
parents. As such any attempts to improve the uptake of
vaccination may be worth targeting at this particular
group of parents. Such interventions could include
mobile immunisation services to vaccinate and gain par-
ental consent. This research indicates that further
research with these hard-to-reach groups into identifying
what acceptable measures could be implemented to help
overcome existing barriers to immunisation may prove
fruitful. One group of parents that school nurses consid-
ered that they would be unlikely to influence were those
who had rejected HPV immunisation. These ‘active rejec-
tor’ parents were viewed as hostile and disruptive during
information sessions. Stretch and colleagues have also
reported that parents who attended information evenings
did not change their view as they had already made a
final decision [11].
Conclusion
To our knowledge this study offers the first insights into
school nurses’ experiences of implementing the HPV
vaccination programme and these may help guide its
future implementation. Overall the first year of the
implementation of the HPV vaccination programme in
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the UK has exceeded school nurses’ expectations and
some of its success may be attributed to the school
nurses’ commitment to the programme. It is also the
case that other factors, including positive newsprint
media reporting that accompanied the introduction of
the HPV vaccination programme may have played a role
[29]. Nevertheless, school nurses also believed that the
programme had vastly increased their workload leading
them to cut back on their core activities and as such
they could no longer dedicate time to offer support to
vulnerable pupils. This unintentional aspect of the pro-
gramme may be worthy of further exploration.
Additional material
Additional file 1: School Nurse Telephone Interview Schedule.
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